McKesson Europe AG
CAKFY
Rangering i aksjer
#4398
McKesson Europe AG is a global provider of logistics and a variety of services... McKesson Europe AG is a global provider of logistics and a variety of services to the pharmaceutical and healthcare industries. Its operations are structured into two main segments: Pharmaceutical Distribution and Retail Pharmacy. The Pharmaceutical Distribution arm focuses on the wholesale supply of medicines and other health-related products. It reaches approximately 40,000 pharmacies and hospitals via 90 wholesale branches and manages 70 distribution centers across Europe. Meanwhile, the Retail Pharmacy division oversees roughly 2,000 company-owned pharmacies and collaborates with around 8,000 partners through its brand program. Under the Lloyds Pharmacy brand, this segment also delivers outpatient medication services, e-commerce solutions, and home care, principally in Belgium, Ireland, Italy, and the United Kingdom. Its offerings extend to traditional prescription drugs, over-the-counter (OTC) items, and various medical services. Furthermore, it supports pharmacists by organizing and managing pharmacy cooperation initiatives in Great Britain, France, Portugal, and Belgium. Established in 1835, the company's roots trace back to its former identity, Celesio AG, before rebranding as McKesson Europe AG in September 2017. Headquartered in Stuttgart, Germany, it operates as a subsidiary of McKesson Corporation.
Aksjekurs
$4.10
Sist synkronisert: 2023-05-23
Markedsverdi
$3.49B
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
DE
Handel McKesson Europe AG (CAKFY)
Kategori
Healthcare
P/E-forhold for McKesson Europe AG (CAKFY)
P/E-forhold per October 2026 TTM: -75.31
Ifølge McKesson Europe AG sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/E-forhold (TTM) -75.31. Ved slutten av 2021 hadde selskapet en P/E på 6.01K.
P/E-forholdshistorikk for McKesson Europe AG fra 2002 til 2026
P/E-forhold ved slutten av hvert år
| År | P/E-forhold | Endre |
|---|---|---|
| 2026 (TTM) | -75.31 | -18.93% |
| 2022 | -92.90 | -101.54% |
| 2021 | 6.01K | -11,135.56% |
| 2020 | -54.50 | -37.89% |
| 2019 | -87.76 | 399.74% |
| 2018 | -17.56 | 222.97% |
| 2017 | -5.44 | -142.37% |
| 2016 | 12.83 | -88.15% |
| 2014 | 108.29 | 345.94% |
| 2013 | 24.28 | -275.57% |
| 2012 | -13.83 | -104.13% |
| 2011 | 334.62 | 2,755.03% |
| 2010 | 11.72 | -99.09% |
| 2009 | 1.29K | -820.13% |
| 2008 | -179.16 | -1,827.49% |
| 2007 | 10.37 | -12.12% |
| 2006 | 11.80 | -10.76% |
| 2005 | 13.23 | -8.69% |
| 2004 | 14.48 | -29.78% |
| 2003 | 20.63 | -21.38% |
| 2002 | 26.23 | 0.00% |
P/E-forhold for lignende selskaper eller konkurrenter
| Selskap | P/E-forhold | Forskjell i P/E-forhold | Land |
|---|---|---|---|
| 26.02 | -134.55% |
US
|
|
| 25.18 | -133.43% |
US
|
|
| 35.41 | -147.02% |
US
|
|
| 13.31 | -117.68% |
US
|
|
| 45.62 | -160.57% |
AU
|
Hvordan lese en P/E-ratio?
Pris/inntjening-forholdet (P/E) måler forholdet mellom aksjekursen og inntjening per aksje.
En lav men positiv P/E indikerer høy inntjening sammenlignet med nåværende verdsettelse, og kan tyde på at selskapet er undervurdert. En høy negativ (nær 0) P/E indikerer store tap.
Selskaper med P/E over 30 eller negativ betraktes vanligvis som "vekstaksjer", hvor investorer forventer vekst eller fremtidig lønnsomhet.
Selskaper med en positiv P/E under 10 anses vanligvis som "verdiaksjer", det vil si at selskapet allerede er lønnsomt, men har begrenset vekstpotensial.